
Neuronetics Reports Third Quarter 2020 Revenue of $12.4 Million, an Increase of 28%
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer …
Read More